Lupus Vasculitis

July 2023 in “ Journal of Ayub Medical College Abbottabad ”

Nauman Ismat Butt, Fahmina Ashfaq, Khalid Mehmood, Sabeen Aftab, Anwar Ali, Minhal Saeed

alopecia malar hyperpigmentation steroids mycophenolate mofetil hydroxychloroquine ANA Anti-Ro antibodies hair loss Plaquenil

Studysummary In this case study, a 30-year-old woman with symptoms including fever, joint pain, and skin ulcers was diagnosed with Lupus Vasculitis and treated with steroids, mycophenolate mofetil, and hydroxychloroquine after tests showed positive anti-nuclear and anti-Ro antibodies and reduced serum complement levels.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on jamc.ayubmed.edu.pk →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community can someone help me identify these pls

in Treatment 10 months ago

The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

community Second shed and more abnormalities

in Treatment 1 upvotes 2 years ago

The user has been using oral finasteride for 15 months and oral minoxidil for 6 months, and developed alopecia areata, for which a dermatologist prescribed calcipotriol/betamethasone. The treatment is helping, but the user is experiencing another shedding phase and is concerned about the effects of the steroid cream and the cause of hair loss.

community 1mg of finasteride/2 sessions of Kenalog injections/ Clobetasol (4 months into treatment)

5 upvotes 2 months ago

The user is undergoing treatment for hair loss using finasteride, Kenalog injections, and Clobetasol, along with vitamin D and collagen supplements. They are considering additional treatments like minoxidil and microneedling, and there is discussion about whether the hair loss is due to stress, alopecia areata, or a scarring condition like lichen planopilaris.

community Got prescribed clobetasol propionate 0.05%

5 upvotes 1 week ago

The user is experiencing diffuse thinning and receded hairline, using dutasteride, minoxidil, and ketoconazole without regrowth, and was prescribed clobetasol propionate 0.05% with salicylic acid for possible inflammation. Other users caution against using the strong steroid without a serious condition, sharing experiences of adverse effects and alternative treatments for scalp issues.

community OND-1 "Cyclosporine A” New hair loss treatment

in Research/Science 28 upvotes 5 months ago

Orient Bio is developing a PLGA formulated version of Cyclosporine A to stimulate hair growth without its immunosuppressant effects. Users discuss various treatments like Clascoterone, PP405, minoxidil, and tacrolimus, expressing hope for new developments and sharing personal experiences with these treatments.

community Reducing Fibrosis in Hair Loss: Topical Pirfenidone

59 upvotes 5 months ago

Topical pirfenidone is highlighted as an effective anti-inflammatory and anti-fibrotic treatment for hair loss, particularly in addressing perifollicular fibrosis, which may enhance the effectiveness of standard treatments like finasteride and minoxidil. The user also uses calcipotriol, MCT oil, ciclopirox shampoo, and benzoyl peroxide shampoo as part of their regimen.

Similar Research

5 / 1000+ results

research ANNOUNCEMENTS

July 2002 in “Australasian Journal of Dermatology”

This announcement in the Australasian Journal of Dermatology provides no new research findings or study results.

research Bone infarcts in a woman with systemic lupus erythematosus and antiphospholipid antibody syndrome

8 citations , February 2006 in “Canadian Medical Association Journal”

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

research Co‐localization of alopecia areata and lichen planopilaris in a patient receiving immunosuppressants: A rare case

1 citations , July 2020 in “Journal of cosmetic dermatology”

This case report describes a patient with systemic lupus erythematosus who developed both alopecia areata and lichen planopilaris despite immunosuppressive treatment, suggesting a shared immunopathogenesis between these disorders.

Managing Azathioprine-Induced Myelosuppression and Alopecia Totalis: Lessons from a Systemic Lupus Erythematosus Patient

research Managing Azathioprine-Induced Myelosuppression and Alopecia Totalis: Lessons from a SLE Patient

January 2024 in “Journal of Clinical Rheumatology and Immunology”

In this case report, researchers described a severe case of myelosuppression and alopecia totalis in a patient with systemic lupus erythematosus following azathioprine treatment, highlighting the importance of monitoring for these uncommon side effects.

research Management of Alopecia and Onychomycosis in a Lupus Patient

July 2024 in “Biomolecular and Health Science Journal”

This case report describes a 33-year-old woman with both subacute cutaneous lupus erythematosus and onychomycosis, highlighting the importance of excluding infections and considering the spectrum of alopecia causes in lupus patients.